LIFECORE BIOMEDICAL, INC. \DE\LFCREarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Legion Partners, L.P. I | 15.40% | 5.9M | ▲ +1.30pp | 2024-10-07 |
| Aron R. English | 12.40% | 4.1M | ▼ -0.10pp | 2024-07-01 |
| S.S. OR | 7.10% | 2.2M | — | 2024-07-05 |
| Scott Miller | 6.30% | 1.9M | — | 2023-06-30 |
| NOS. OF ABOVE PERSONS | 5.15% | 1.6M | — | 2023-08-15 |
| BlackRock, Inc. | 1.80% | 532.0K | — | 2023-07-07 |
| OF ABOVE PERSONS | 0.00% | 3.6K | — | 2024-02-09 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-02 | Salus Thomas D. | Chief Legal & Administration | Grant | 30.0K | — | — |
1–1 of 1